On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders
- PMID: 19187344
- PMCID: PMC2649670
- DOI: 10.1111/j.1365-2133.2008.08958.x
On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders
Abstract
Corticotropin-releasing hormone (CRH; previously known as corticotropin-releasing factor) is the central regulator of the hypothalamic-pituitary-adrenal (HPA) axis, which is the main organizer of the body’s response to stress.– Stress induces the hypothalamic production and release of CRH, which then causes the activation of the CRH receptor (CRHR) type 1 (CRHR-1) in the anterior pituitary to stimulate ACTH release, as well as proopiomelanocortin (POMC) expression and processing. ,, ACTH stimulates the production and secretion of cortisol (humans) or corticosterone (rodents) by the adrenal cortex. These steroids regulate the body’s response to counteract effects of the stressor and suppress the HPA through the negative feedback mechanism. CRH/POMC expression can also be activated by the cytokines interleukin (IL)-1, IL-6 and tumour necrosis factor (TNF)-α, thus involving the immune system in the central regulation of the HPA axis. In addition, CRH together with related urocortin (URC) peptides regulate behavioural, autonomic, endocrine, reproductive, cardiovascular, gastrointestinal and metabolic functions both on the central and on the peripheral levels, and CRH has immunosuppressive effects via the HPA.,– It is also accepted that peripheral CRH and related peptides have predominantly proinflammatory functions,, and in this way differ from their central immunosuppressive activity. However, recent data also suggest that the peripheral CRH may have dual effects: a direct, short-term proinflammatory function and an indirect, remote anti-inflammatory function.–
Figures
Comment on
-
Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris.Br J Dermatol. 2009 Feb;160(2):345-52. doi: 10.1111/j.1365-2133.2008.08959.x. Epub 2008 Dec 10. Br J Dermatol. 2009. PMID: 19077080
References
-
- Vale W, Spiess J, Rivier C, et al. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 1981;213:1394–7. - PubMed
-
- Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995;332:1351–62. - PubMed
-
- Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992;267:1244–52. - PubMed
-
- Selye H. A syndrome produced by various noxious agents. Nature. 1936;138:32–3.
-
- Rivier C, Vale W. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature. 1983;305:325–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
